CD8A and neoplasm: However, the mHCC3 had its own unique characteristic: CTNNB1 mutations was rare in this subtype; it was the only subtype that benefited from enrichment in aDC; moreover, CD8+ T cell enrichment showed the lowest HR value, suggesting a high anti-tumor activity of effector T cells in tumors of this subtype.